Research Paper Volume 13, Issue 6 pp 8777—8796

Comprehensive analysis of expression and prognostic value of the claudin family in human breast cancer

The RFS of mRNA levels of claudins in all patients with breast cancer (Kaplan–Meier plotter). (A) CLDN2; (B) CLDN3; (C) CLDN5; (D) CLDN6; (E) CLDN9; (F) CLDN10; (G) CLDN11; (H) CLDN14; (I) CLDN15; (J) CLDN16; (K) CLDN17; (L) CLDN18; (M) CLDN19; (N) CLDN20. Abbreviation: RFS, relapse-free survival.

Figure 5. The RFS of mRNA levels of claudins in all patients with breast cancer (Kaplan–Meier plotter). (A) CLDN2; (B) CLDN3; (C) CLDN5; (D) CLDN6; (E) CLDN9; (F) CLDN10; (G) CLDN11; (H) CLDN14; (I) CLDN15; (J) CLDN16; (K) CLDN17; (L) CLDN18; (M) CLDN19; (N) CLDN20. Abbreviation: RFS, relapse-free survival.